Case Study: SMA Type I Natural History Study and Its Regulatory Impact
Case Study: SMA Type I Natural History Study and Its Regulatory Impact How Natural History Data from SMA Type I Shaped Drug Approval Pathways Introduction: The Importance of Natural History in Spinal Muscular Atrophy Spinal Muscular Atrophy (SMA) Type I is one of the most severe and rapidly progressing rare diseases affecting infants. With onset…
Read More “Case Study: SMA Type I Natural History Study and Its Regulatory Impact” »
